0 TSX News - June 6, 2024Bombardier Defense and ADAC Announce Order of a new Challenger 650 Aircraft for Medevac UseBombardier Defense signs deal with German-based operator Aero-Dienst GmbH, a 100% subsidiary of ADAC SE, for a new Bombardier Challenger […]Read More
0 TSX Venture News - June 6, 2024Standard Uranium Intersects Local Anomalous Radioactivity and Hydrothermal Alteration at Canary Project; Concludes Inaugural Drill ProgramVANCOUVER, British Columbia, June 06, 2024 (GLOBE NEWSWIRE) — Standard Uranium Ltd. (“Standard Uranium” or the “Company”) (TSX-V: STND) (OTCQB: […]Read More
0 NYSE Companies - June 6, 2024Vishay Intertechnology Expands Resistor Product PortfolioMALVERN, Pa., June 06, 2024 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH), one of the world’s largest manufacturers of […]Read More
0 NYSE Companies - June 6, 2024O-I GLASS TRANSFORMS PROCESSING OF RECYCLED GLASS WITH INNOVATIVE MOBILE SYSTEMTransformative mobile equipment brings glass recycling solutions to untapped markets Movable on a truck bed, the modular system enables full-service, […]Read More
0 TSX News - June 6, 2024Xtract One Technologies Secures Contracts with NBA, MLB & NHL Teams Following New U.S. DHS SAFETY Act DesignationTORONTO, June 06, 2024 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”), a leading […]Read More
0 NYSE Companies - June 6, 2024B2Gold and Sandbox Royalties Partner to Create Versamet Royalties; B2Gold Receives $90 Million Equity Interest in VersametVANCOUVER, British Columbia, June 06, 2024 (GLOBE NEWSWIRE) — B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or […]Read More
0 NASDAQ Companies - June 6, 2024IAE AG and FTAI Aviation Sign Strategic V2500® Engine Maintenance Services AgreementThe V2500® engine powers commercial, cargo and military aircraft, and has a long track record of providing reliable and efficient […]Read More
0 NASDAQ Companies - June 6, 2024Chemomab Therapeutics Presents Data Supporting the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2024 and a Gordon Research Conference—Ex Vivo Studies Using Clinical Samples from Patients with Liver Fibrosis Reinforce the Anti-Fibrotic Activity of CM-101 by Showing the […]Read More